Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Complementary Medicines
Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Cell Death Dis ; 8(2): e2584, 2017 02 02.
Article in English | MEDLINE | ID: mdl-28151483

ABSTRACT

Immunotherapeutic approaches to manage patients with advanced gastrointestinal malignancies are desired; however, mechanisms to incite tumor-specific immune responses remain to be elucidated. Rose bengal (RB) is toxic at low concentrations to malignant cells and may induce damage-associated molecular patterns; therefore, we investigated its potential as an immunomodulator in colon cancer. Murine and human colon cancer lines were treated with RB (10% in saline/PV-10) for cell cycle, cell death, and apoptosis assays. Damage-associated molecular patterns were assessed with western blot, ELISA, and flow cytometry. In an immunocompetent murine model of colon cancer, we demonstrate that tumors regress upon RB treatment, and that RB induces cell death in colon cancer cells through G2/M growth arrest and predominantly necrosis. RB-treated colon cancer cells expressed distinct hallmarks of immunogenic cell death (ICD), including enhanced expression of calreticulin and heat-shock protein 90 on the cell surface, a decrease in intracellular ATP, and the release of HMGB1. To confirm the ICD phenotype, we vaccinated immunocompetent animals with syngeneic colon cancer cells treated with RB. RB-treated tumors served as a vaccine against subsequent challenge with the same CT26 colon cancer tumor cells, and vaccination with in vitro RB-treated cells resulted in slower tumor growth following inoculation with colon cancer cells, but not with syngeneic non-CT26 cancer cells, suggesting a specific antitumor immune response. In conclusion, RB serves as an inducer of ICD that contributes to enhanced specific antitumor immunity in colorectal cancer.


Subject(s)
Antineoplastic Agents/immunology , Antineoplastic Agents/pharmacology , Cell Death/drug effects , Cell Death/immunology , Colonic Neoplasms/drug therapy , Colonic Neoplasms/immunology , Rose Bengal/pharmacology , Animals , Apoptosis/drug effects , Apoptosis/immunology , Calreticulin/metabolism , Cell Line, Tumor , Colonic Neoplasms/metabolism , HCT116 Cells , HMGB1 Protein/metabolism , HSP90 Heat-Shock Proteins/metabolism , HT29 Cells , Humans , Mice , Mice, Inbred BALB C , Necrosis/drug therapy , Necrosis/immunology , Necrosis/metabolism
2.
Arch Immunol Ther Exp (Warsz) ; 64(5): 417-23, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27197661

ABSTRACT

Program death-1 (PD-1) is a co-inhibitory receptor inducibly expressed on activated T cells. PD-1 has been reported to be associated with the development of several autoimmune diseases including rheumatoid arthritis, but the precise cellular and molecular mechanisms have not been fully elucidated. To study the role of PD-1 in the pathogenesis of rheumatoid arthritis and the possible underlying mechanisms, we performed collagen-induced arthritis (CIA) in C57BL/6 mice. Here, we show that PD-1 deficiency leads to the development of severe CIA in mice. When analyzing T cells from CIA mice ex vivo, we noticed aberrant antigen-specific Th17 responses in mice lacking PD-1. This is possibly due to deregulated activation of PKC-θ and Akt. In support of this notion, treating Pdcd1 (-/-) mice with an inhibitor of PI3-kinase that is upstream of PKC-θ and Akt significantly suppressed the disease severity. Therefore, our data indicate that PD-1 dampens antigen-specific Th17 response, thus inhibiting the disease.


Subject(s)
Arthritis, Rheumatoid/immunology , Autoimmune Diseases/immunology , Programmed Cell Death 1 Receptor/metabolism , Th17 Cells/cytology , Animals , Arthritis/immunology , Arthritis/metabolism , Arthritis, Experimental , Arthritis, Rheumatoid/metabolism , Autoimmune Diseases/metabolism , Cell Differentiation , Collagen/chemistry , Disease Models, Animal , Flow Cytometry , Humans , Lymphocyte Activation , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation
3.
Am J Physiol Endocrinol Metab ; 287(4): E744-9, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15165995

ABSTRACT

As the fourth most abundant anion in the body, sulfate plays an essential role in numerous physiological processes. One key protein involved in transcellular transport of sulfate is the sodium-sulfate cotransporter NaSi-1, and previous studies suggest that vitamin D modulates sulfate homeostasis by regulating NaSi-1 expression. In the present study, we found that, in mice lacking the vitamin D receptor (VDR), NaSi-1 expression in the kidney was reduced by 72% but intestinal NaSi-1 levels remained unchanged. In connection with these findings, urinary sulfate excretion was increased by 42% whereas serum sulfate concentration was reduced by 50% in VDR knockout mice. Moreover, levels of hepatic glutathione and skeletal sulfated proteoglycans were also reduced by 18 and 45%, respectively, in the mutant mice. Similar results were observed in VDR knockout mice after their blood ionized calcium levels and rachitic bone phenotype were normalized by dietary means, indicating that vitamin D regulation of NaSi-1 expression and sulfate metabolism is independent of its role in calcium metabolism. Treatment of wild-type mice with 1,25-dihydroxyvitamin D3 or vitamin D analog markedly stimulated renal NaSi-1 mRNA expression. These data provide strong in vivo evidence that vitamin D plays a critical role in sulfate homeostasis. However, the observation that serum sulfate and skeletal proteoglycan levels in normocalcemic VDR knockout mice remained low in the absence of rickets and osteomalacia suggests that the contribution of sulfate deficiency to development of rickets and osteomalacia is minimal.


Subject(s)
Calcitriol/pharmacology , Cation Transport Proteins/metabolism , Homeostasis/physiology , Sulfates/metabolism , Symporters/metabolism , Vitamin D/physiology , Animals , Blotting, Northern , Bone and Bones/metabolism , Bone and Bones/pathology , Cation Transport Proteins/genetics , Cell Nucleus/metabolism , DNA Primers , DNA, Complementary/biosynthesis , DNA, Complementary/genetics , Extracellular Matrix/metabolism , Glutathione/metabolism , Homeostasis/drug effects , Kidney/metabolism , Liver/metabolism , Mice , Mice, Knockout , Proteoglycans/metabolism , RNA/biosynthesis , RNA/isolation & purification , Receptors, Calcitriol/genetics , Receptors, Cytoplasmic and Nuclear/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sodium Sulfate Cotransporter , Sulfates/blood , Sulfates/urine , Symporters/genetics
SELECTION OF CITATIONS
SEARCH DETAIL